cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.jwn7hu
title: Occurrence Download

description: A dataset containing 15405 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ricinus communis",
 "Country is United States of America",
 "HasCoordinate is true"
 ]
}

 The dataset includes 15405 records from 91 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0025259-250811113504898/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.15597387
title: trabajo de seminario de investigacion sandry cordoba
title: ¿qué criterios utilizarías para evaluar si una fuente electrónica es confiable en el ámbito jurídico? Apóyate en un ejemplo
DOI: 10.5281/zenodo.15597388
title: trabajo de seminario de investigacion sandry cordoba
title: ¿qué criterios utilizarías para evaluar si una fuente electrónica es confiable en el ámbito jurídico? Apóyate en un ejemplo
DOI: 10.15468/dl.j98abh
title: Occurrence Download

description: A dataset containing 141 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-7.46064 19.82579,-22.32913 14.94892,-12.93225 -3.7259,4.19625 -7.88908,14.66367 -13.36068,33.21954 -14.19332,40.83221 0.79412,31.43532 6.50362,3.19629 15.62362,-7.46064 19.82579))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Dalbergia mayumbensis Baker f."
 ]
}

 The dataset includes 141 records from 24 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0014678-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ewmrhb
title: Occurrence Download

description: A dataset containing 5315 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Musa ×paradisiaca L."
 ]
}

 The dataset includes 5315 records from 345 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0021870-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.4228/zalf-4mye-ed59
title: The Prussian Land Survey (Preußische Landesaufname) - digitization (vectorization) of historical maps

description: The set contains vector data of the 1880 timeline which is derived from the Prussian Land Survey map for the Uckermark region. 
The original map sheets are stored in the Map Section of the National State Library in Berlin. 
A set of forest data from these maps was bought from the Eberswalde Forestry State Centre of Excellence (LFE). These data were checked and partly adjusted to our own field experiences  and all other land-cover types were added by digitizing.

Borders of the old Uckermark from: Fidicin E (1864) Die Territorien der Mark Brandenburg oder
Geschichte der einzelnen Kreise, Städte, Rittergüter und Dörfer in derselben als Fortsetzung des Landbuchs Kaiser Karl’s, Vol. IV. Bd. 4: Kreis Prenzlau. Kreis, Templin. Kreis Angermünde.
Reprint in 1974, de Gruyter, Berlin
DOI: 10.5281/zenodo.15076034
title: Interviews with SHARED GREEN DEAL Experiment Participants - Preserving Biodiversity

description: The SHARED GREEN DEAL (Social sciences & Humanities for Achieving a Responsible, Equitable and Desirable GREEN DEAL) project aims to drive progress towards EU Green Deal targets. At the heart of this EU Horizon 2020 project are six streams of innovative, participatory social experiments focused on six Green Deal priority areas: Clean Energy, Circular Economy, Efficient Renovations, Sustainable Mobility, Sustainable Food, and Preserving Biodiversity. Experiments for each of the six streams were implemented in four locations across Europe between April 2023 and June 2024. The experiments were led by local partners (NGOs and local, regional, or national governments). Whilst the activities undertaken by each of the local partners differed across experiment streams, a core component of each experiment was that different stakeholders were involved.

Upon the completion of the SHARED GREEN DEAL experiments, each local partner conducted 10 interviews with participants involved in their experiment (totalling 40 interviews in each stream, and 240 interviews across the project). The purpose of these interviews was to learn more individuals' experiences of participating in the local experiment. The interviews were carried out in spring 2024.

Within the Preserving Biodiversity stream questions covered a range of topics including their general experience of the experiment, the impact of study circles on understanding/developing solutions for biodiversity preservation, the social dynamics and impacts of the experiment, and recommendations for policymakers/those interested in undertaking activities similar to those undertaken in the experiment. 

This Zenodo upload includes 1) the consent form and interview protocol used during the interviews and 2) the anonymised interview transcripts for the Preserving Biodiversity experiment stream. These interviews were conducted by the experiment stream's local partners: Pososki Razvojni Cent (Slovenia), Environment and Health (Sweden), Municipality of Amarous (Greece), and Ballyhoura Development (Ireland). There are 40 transcripts in total.
DOI: 10.5281/zenodo.15076035
title: Interviews with SHARED GREEN DEAL Experiment Participants - Preserving Biodiversity

description: The SHARED GREEN DEAL (Social sciences & Humanities for Achieving a Responsible, Equitable and Desirable GREEN DEAL) project aims to drive progress towards EU Green Deal targets. At the heart of this EU Horizon 2020 project are six streams of innovative, participatory social experiments focused on six Green Deal priority areas: Clean Energy, Circular Economy, Efficient Renovations, Sustainable Mobility, Sustainable Food, and Preserving Biodiversity. Experiments for each of the six streams were implemented in four locations across Europe between April 2023 and June 2024. The experiments were led by local partners (NGOs and local, regional, or national governments). Whilst the activities undertaken by each of the local partners differed across experiment streams, a core component of each experiment was that different stakeholders were involved.

Upon the completion of the SHARED GREEN DEAL experiments, each local partner conducted 10 interviews with participants involved in their experiment (totalling 40 interviews in each stream, and 240 interviews across the project). The purpose of these interviews was to learn more individuals' experiences of participating in the local experiment. The interviews were carried out in spring 2024.

Within the Preserving Biodiversity stream questions covered a range of topics including their general experience of the experiment, the impact of study circles on understanding/developing solutions for biodiversity preservation, the social dynamics and impacts of the experiment, and recommendations for policymakers/those interested in undertaking activities similar to those undertaken in the experiment. 

This Zenodo upload includes 1) the consent form and interview protocol used during the interviews and 2) the anonymised interview transcripts for the Preserving Biodiversity experiment stream. These interviews were conducted by the experiment stream's local partners: Pososki Razvojni Cent (Slovenia), Environment and Health (Sweden), Municipality of Amarous (Greece), and Ballyhoura Development (Ireland). There are 40 transcripts in total.
DOI: 10.57701/suf.rtbn.2017.1-0
title: Versichertenrentenbestand 2017
title: SUF
title: RTBN

description: Scientific Use File Versichertenrentenbestand (SUF.RTBN):Grundlage des Querschnittsdatensatzes SUF.RTBN ist die Rentenbestandsstatistik (§ 7 RSVwV, SK90), die alle Rentenbestandsfälle zum Dezember des Berichtsjahres umfasst. Die Grundgesamtheit des SUF.RTBN bilden Alters- und Erwerbsminderungsrenten sowie reine Kindererziehungsleistungen. Die Größe der Zufallsstichprobe beträgt 1 Prozent. Berichtet wird neben demographischen Angaben über wichtige rentenrechtliche Sachverhalte wie beispielsweise Rentenhöhe, Komponenten des Rentenzahlbetrages, Entgeltpunkte sowie angerechnete versicherungsrechtliche Zeiten.
DOI: 10.17632/krpf84t9m5
title: banco de dados sono e ansiedade

description: Este banco de dados contém informações sociodemográficas e psicológicas de 100 participantes adultos simulados para fins de pesquisa. Os dados foram gerados sinteticamente com distribuições realistas com o objetivo de representar um cenário plausível em estudos de saúde mental e sono. Este conjunto de dados pode ser utilizado para simular análises de correlação entre sono e ansiedade, estudos observacionais, ou treinamento de modelos estatísticos ou de aprendizado de máquina com dados de saúde mental.
DOI: 10.17632/krpf84t9m5.1
title: banco de dados sono e ansiedade

description: Este banco de dados contém informações sociodemográficas e psicológicas de 100 participantes adultos simulados para fins de pesquisa. Os dados foram gerados sinteticamente com distribuições realistas com o objetivo de representar um cenário plausível em estudos de saúde mental e sono. Este conjunto de dados pode ser utilizado para simular análises de correlação entre sono e ansiedade, estudos observacionais, ou treinamento de modelos estatísticos ou de aprendizado de máquina com dados de saúde mental.
DOI: 10.17611/dp/22977693
title: Global ShakeMovie synthetic for December 09, 2024 MW 5.8 NEVADA
DOI: 10.17611/dp/22977697
title: Global ShakeMovie synthetic for December 13, 2024 MW 6.4 CHILE-ARGENTINA BORDER REGION
DOI: 10.17611/dp/22977701
title: Global ShakeMovie synthetic for December 15, 2024 MW 5.9 TONGA ISLANDS
DOI: 10.17611/dp/22977705
title: Global ShakeMovie synthetic for December 16, 2024 MW 5.5 SERAM, INDONESIA
DOI: 10.17611/dp/22977709
title: Global ShakeMovie synthetic for December 17, 2024 MW 7.3 VANUATU ISLANDS
DOI: 10.17611/dp/22977713
title: Global ShakeMovie synthetic for December 17, 2024 MW 5.6 FIJI ISLANDS REGION
DOI: 10.17611/dp/22985007
title: Global ShakeMovie synthetic for November 11, 2024 MW 5.6 MARIANA ISLANDS
DOI: 10.17611/dp/22985011
title: Global ShakeMovie synthetic for November 15, 2024 MW 5.5 BALLENY ISLANDS REGION
DOI: 10.17611/dp/22985015
title: Global ShakeMovie synthetic for November 16, 2024 MW 5.5 SANTA CRUZ ISLANDS
DOI: 10.17611/dp/22985019
title: Global ShakeMovie synthetic for November 18, 2024 MW 5.3 SOUTHERN MID-ATLANTIC RIDGE
DOI: 10.17611/dp/22985023
title: Global ShakeMovie synthetic for November 19, 2024 MW 5.5 TONGA ISLANDS
DOI: 10.17611/dp/22985027
title: Global ShakeMovie synthetic for November 26, 2024 MW 5.5 KURIL ISLANDS
DOI: 10.17611/dp/22985031
title: Global ShakeMovie synthetic for December 07, 2024 MW 5.4 SOUTHEAST OF EASTER ISLAND
DOI: 10.17611/dp/22985035
title: Global ShakeMovie synthetic for December 08, 2024 MW 5.3 CENTRAL EAST PACIFIC RISE
DOI: 10.17611/dp/22985039
title: Global ShakeMovie synthetic for December 09, 2024 MW 5.4 ANDREANOF ISLANDS, ALEUTIAN IS.
DOI: 10.17611/dp/22985043
title: Global ShakeMovie synthetic for December 17, 2024 MW 5.3 NORTHERN EAST PACIFIC RISE
DOI: 10.17611/dp/22985047
title: Global ShakeMovie synthetic for December 19, 2024 MW 5.7 WEST OF MACQUARIE ISLAND
DOI: 10.17611/dp/22990367
title: Global ShakeMovie synthetic for December 21, 2024 MW 6.1 VANUATU ISLANDS
DOI: 10.17611/dp/22990371
title: Global ShakeMovie synthetic for December 23, 2024 MW 5.8 CUBA REGION
DOI: 10.17611/dp/22990375
title: Global ShakeMovie synthetic for December 24, 2024 MW 5.9 LA RIOJA PROVINCE, ARGENTINA
DOI: 10.17611/dp/22990379
title: Global ShakeMovie synthetic for December 25, 2024 MW 5.6 FIJI ISLANDS REGION
DOI: 10.17611/dp/22995196
title: Global ShakeMovie synthetic for December 26, 2024 MW 5.8 SOUTHEAST OF HONSHU, JAPAN
DOI: 10.17611/dp/22995200
title: Global ShakeMovie synthetic for December 27, 2024 MW 6.0 NORTHERN MID-ATLANTIC RIDGE
DOI: 10.17611/dp/22995204
title: Global ShakeMovie synthetic for December 27, 2024 MW 6.8 KURIL ISLANDS
DOI: 10.17611/dp/23001631
title: Global ShakeMovie synthetic for December 28, 2024 MW 5.5 FIJI ISLANDS REGION
DOI: 10.17611/dp/23001635
title: Global ShakeMovie synthetic for December 27, 2024 MW 5.5 MINDANAO, PHILIPPINES
DOI: 10.17611/dp/23001639
title: Global ShakeMovie synthetic for December 28, 2024 MW 5.6 SOUTHERN MID-ATLANTIC RIDGE
DOI: 10.17611/dp/23001643
title: Global ShakeMovie synthetic for December 30, 2024 MW 5.6 LUZON, PHILIPPINES
DOI: 10.17611/dp/23001647
title: Global ShakeMovie synthetic for December 30, 2024 MW 5.6 OFF COAST OF CENTRAL CHILE
DOI: 10.17611/dp/23003755
title: Global ShakeMovie synthetic for January 01, 2025 MW 5.6 VANUATU ISLANDS
DOI: 10.17611/dp/23003759
title: Global ShakeMovie synthetic for January 01, 2025 MW 6.2 SOUTH SANDWICH ISLANDS REGION
DOI: 10.17611/dp/23004519
title: Global ShakeMovie synthetic for January 02, 2025 MW 5.5 BALLENY ISLANDS REGION
DOI: 10.17611/dp/23004523
title: Global ShakeMovie synthetic for January 02, 2025 MW 6.1 NORTHERN CHILE
DOI: 10.17611/dp/23004527
title: Global ShakeMovie synthetic for January 02, 2025 MW 5.4 ETHIOPIA
DOI: 10.17611/dp/23005493
title: Global ShakeMovie synthetic for January 03, 2025 MW 5.5 SOUTH SANDWICH ISLANDS REGION
DOI: 10.17611/dp/23007468
title: Global ShakeMovie synthetic for January 03, 2025 MW 5.5 ETHIOPIA
DOI: 10.17611/dp/23007472
title: Global ShakeMovie synthetic for January 04, 2025 MW 5.7 ETHIOPIA
DOI: 10.17611/dp/23010100
title: Global ShakeMovie synthetic for January 05, 2025 MW 6.2 EL SALVADOR
DOI: 10.17611/dp/23014964
title: Global ShakeMovie synthetic for January 07, 2025 MW 7.1 XIZANG
DOI: 10.17611/dp/23014968
title: Global ShakeMovie synthetic for January 07, 2025 MW 5.7 SOUTHEAST OF HONSHU, JAPAN
DOI: 10.17611/dp/23018584
title: Global ShakeMovie synthetic for January 08, 2025 MW 5.6 QINGHAI, CHINA
DOI: 10.17611/dp/23021208
title: Global ShakeMovie synthetic for January 09, 2025 MW 5.8 EL SALVADOR
DOI: 10.17611/dp/23024007
title: Global ShakeMovie synthetic for January 10, 2025 MW 5.6 NEAR WEST COAST OF COLOMBIA
DOI: 10.17611/dp/23031600
title: Global ShakeMovie synthetic for January 13, 2025 MW 5.5 MINDANAO, PHILIPPINES
DOI: 10.15468/dl.6f8uhd
title: Occurrence Download

description: A dataset containing 369197 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasCoordinate is true",
 "TaxonKey is Symphytum officinale"
 ]
}

 The dataset includes 369197 records from 1709 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0025549-250811113504898/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.16963237
title: Updating and Expanding the Key to European Megaselia (Diptera, Phoridae): From Disney's Britain to a Continental Fauna, with 393 Additions and Four New Species

description: This dataset is core part of the article "Updating and Expanding the Key to European Megaselia (Diptera, Phoridae): From Disney's Britain to a Continental Fauna, with 393 Additions and Four New Species" (Supplementary 1), and provides a comprehensive list of additions to Disney’s 1989 British key for the genus Megaselia. The file expands the original 221 species to include 393 additional taxa, covering all described Palearctic species.
DOI: 10.5281/zenodo.16963238
title: Updating and Expanding the Key to European Megaselia (Diptera, Phoridae): From Disney's Britain to a Continental Fauna, with 393 Additions and Four New Species

description: This dataset is core part of the article "Updating and Expanding the Key to European Megaselia (Diptera, Phoridae): From Disney's Britain to a Continental Fauna, with 393 Additions and Four New Species" (Supplementary 1), and provides a comprehensive list of additions to Disney’s 1989 British key for the genus Megaselia. The file expands the original 221 species to include 393 additional taxa, covering all described Palearctic species.
DOI: 10.6084/m9.figshare.28504943
title: Epidural Hydromorphone for Postpartum Pain Management After Vaginal Delivery: A Randomized Clinical Trial

description: <b>ABSTRACT</b><b>Background</b> Mothers frequently experience differing intensities of postpartum analgesia following vaginal delivery; however, there remains a deficiency of effective and readily available modalities for postpartum pain management. This study aims to assess the analgesic efficacy and safety profile of epidural hydromorphone in the treatment of postpartum pain.<b>Methods </b>This randomized controlled trial enrolled 460 full-term women who had a full-term vaginal delivery. The participants received either epidural hydromorphone (HY group) or normal saline (NS group). The primary outcome was pain scores within 48 hours postpartum, with the occurrence of adverse events systematically documented.<b>Results</b> Within 48 hours post-treatment, median pain scores were significantly lower in HY group compared to NS group (P &lt; 0.001). The proportion of mothers with postpartum pain scores ≤3 was significantly higher in the HY group than in the NS group (76.47% vs. 27.93%; OR 2.81, 95% CI 2.24-3.53). Postpartum analgesic medication requirements were reduced in the HY group (6.79% vs. 24.77%; OR 0.39, 95% CI 0.25-0.61), and the time to first additional analgesic was prolonged (15.63 ± 5.98 vs. 12.01 ± 5.01 h). However, the HY group exhibited increased rates of nausea and vomiting (26.24% vs. 8.11%; RR 1.72, 95% CI 1.45-2.04), dizziness (25.34% vs. 14.41%; RR 1.34, 95% CI 1.13-1.66), pruritus (32.58% vs. 7.21%; RR 1.95, 95% CI 1.67-2.28), and urinary retention (20.81% vs. 7.66%; RR 1.59, 95% CI 1.32-1.91). Conversely, the incidence of sleep disturbances was lower in the HY group (5.43% vs. 30.18%; RR 0.27, 95% CI 0.16-0.45). The HY group demonstrated improved early bedside mobility (76.02% vs. 64.41%) and overall satisfaction (89.59% vs. 63.51%). Postpartum inflammatory markers, including leukocyte count (13.53 ± 3.26 vs. 13.91 ± 3.20) and ultrasensitive C-reactive protein levels (62.69 ± 38.00 vs. 65.93 ± 36.20), were lower in the HY group, although these differences did not reach statistical significance.<b>Conclusions</b> Epidural hydromorphone effectively reduced postpartum pain, with manageable side effects. Clinicians should balance the benefits and potential risks when considering postpartum analgesia.<b>Key Points</b><b>Question</b>In women post-vaginal delivery, does the administration of epidural hydromorphone offer superior analgesia and enhance maternal satisfaction relative to a placebo (normal saline)?<br><b>Findings</b>Epidural hydromorphone demonstrated a statistically significant reduction in postpartum pain scores, a decreased requirement for supplemental analgesics, and enhanced maternal satisfaction. Observed adverse effects included nausea, dizziness, pruritus, and urinary retention, all of which were deemed manageable.<br><b>Meaning</b>Epidural hydromorphone presents as a viable analgesic modality for the management of postpartum pain following vaginal delivery, offering effective pain relief within an acceptable safety profile.<br>
DOI: 10.6084/m9.figshare.28504943.v2
title: Epidural Hydromorphone for Postpartum Pain Management After Vaginal Delivery: A Randomized Clinical Trial

description: <b>ABSTRACT</b><b>Background</b> Mothers frequently experience differing intensities of postpartum analgesia following vaginal delivery; however, there remains a deficiency of effective and readily available modalities for postpartum pain management. This study aims to assess the analgesic efficacy and safety profile of epidural hydromorphone in the treatment of postpartum pain.<b>Methods </b>This randomized controlled trial enrolled 460 full-term women who had a full-term vaginal delivery. The participants received either epidural hydromorphone (HY group) or normal saline (NS group). The primary outcome was pain scores within 48 hours postpartum, with the occurrence of adverse events systematically documented.<b>Results</b> Within 48 hours post-treatment, median pain scores were significantly lower in HY group compared to NS group (P &lt; 0.001). The proportion of mothers with postpartum pain scores ≤3 was significantly higher in the HY group than in the NS group (76.47% vs. 27.93%; OR 2.81, 95% CI 2.24-3.53). Postpartum analgesic medication requirements were reduced in the HY group (6.79% vs. 24.77%; OR 0.39, 95% CI 0.25-0.61), and the time to first additional analgesic was prolonged (15.63 ± 5.98 vs. 12.01 ± 5.01 h). However, the HY group exhibited increased rates of nausea and vomiting (26.24% vs. 8.11%; RR 1.72, 95% CI 1.45-2.04), dizziness (25.34% vs. 14.41%; RR 1.34, 95% CI 1.13-1.66), pruritus (32.58% vs. 7.21%; RR 1.95, 95% CI 1.67-2.28), and urinary retention (20.81% vs. 7.66%; RR 1.59, 95% CI 1.32-1.91). Conversely, the incidence of sleep disturbances was lower in the HY group (5.43% vs. 30.18%; RR 0.27, 95% CI 0.16-0.45). The HY group demonstrated improved early bedside mobility (76.02% vs. 64.41%) and overall satisfaction (89.59% vs. 63.51%). Postpartum inflammatory markers, including leukocyte count (13.53 ± 3.26 vs. 13.91 ± 3.20) and ultrasensitive C-reactive protein levels (62.69 ± 38.00 vs. 65.93 ± 36.20), were lower in the HY group, although these differences did not reach statistical significance.<b>Conclusions</b> Epidural hydromorphone effectively reduced postpartum pain, with manageable side effects. Clinicians should balance the benefits and potential risks when considering postpartum analgesia.<b>Key Points</b><b>Question</b>In women post-vaginal delivery, does the administration of epidural hydromorphone offer superior analgesia and enhance maternal satisfaction relative to a placebo (normal saline)?<br><b>Findings</b>Epidural hydromorphone demonstrated a statistically significant reduction in postpartum pain scores, a decreased requirement for supplemental analgesics, and enhanced maternal satisfaction. Observed adverse effects included nausea, dizziness, pruritus, and urinary retention, all of which were deemed manageable.<br><b>Meaning</b>Epidural hydromorphone presents as a viable analgesic modality for the management of postpartum pain following vaginal delivery, offering effective pain relief within an acceptable safety profile.<br>